These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 21684160

  • 1. SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors.
    Sála M, De Palma AM, Hřebabecký H, Dejmek M, Dračínský M, Leyssen P, Neyts J, Mertlíková-Kaiserová H, Nencka R.
    Bioorg Med Chem Lett; 2011 Jul 15; 21(14):4271-5. PubMed ID: 21684160
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Design, synthesis, and biological evaluation of novel coxsackievirus B3 inhibitors.
    Sála M, De Palma AM, Hrebabecký H, Nencka R, Dracínský M, Leyssen P, Neyts J, Holý A.
    Bioorg Med Chem; 2010 Jun 15; 18(12):4374-84. PubMed ID: 20576576
    [Abstract] [Full Text] [Related]

  • 4. 9-Arylpurines as a novel class of enterovirus inhibitors.
    Aguado L, Thibaut HJ, Priego EM, Jimeno ML, Camarasa MJ, Neyts J, Pérez-Pérez MJ.
    J Med Chem; 2010 Jan 14; 53(1):316-24. PubMed ID: 19924996
    [Abstract] [Full Text] [Related]

  • 5. Efficient synthesis and anti-enteroviral activity of 9-arylpurines.
    Aguado L, Canela MD, Thibaut HJ, Priego EM, Camarasa MJ, Leyssen P, Neyts J, Pérez-Pérez MJ.
    Eur J Med Chem; 2012 Mar 14; 49():279-88. PubMed ID: 22305341
    [Abstract] [Full Text] [Related]

  • 6. Synthesis of novel purine-based coxsackievirus inhibitors bearing polycylic substituents at the N-9 position.
    Dejmek M, Sála M, Plačková P, Hřebabecký H, Mascarell Borredà L, Neyts J, Dračínský M, Procházková E, Jansa P, Leyssen P, Mertlíková-Kaiserová H, Nencka R.
    Arch Pharm (Weinheim); 2014 Jul 14; 347(7):478-85. PubMed ID: 24652670
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
    Wang YX, Li YH, Li YH, Gao RM, Wang HQ, Liu YX, Gao LM, Lu QN, Jiang JD, Song DQ.
    Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5787-90. PubMed ID: 21880491
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and anti-CVB 3 evaluation of substituted 5-nitro-2-phenoxybenzonitriles.
    Pürstinger G, De Palma AM, Zimmerhofer G, Huber S, Ladurner S, Neyts J.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5123-5. PubMed ID: 18710805
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
    Xue F, Luo X, Ye C, Ye W, Wang Y.
    Bioorg Med Chem; 2011 Apr 15; 19(8):2641-9. PubMed ID: 21441033
    [Abstract] [Full Text] [Related]

  • 10. Structure-activity relationship of N-benzenesulfonyl matrinic acid derivatives as a novel class of coxsackievirus B3 inhibitors.
    Wang SG, Kong LY, Li YH, Cheng XY, Su F, Tang S, Bi CW, Jiang JD, Li YH, Song DQ.
    Bioorg Med Chem Lett; 2015 Sep 01; 25(17):3690-3. PubMed ID: 26112440
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors.
    Gao LM, Tang S, Wang YX, Gao RM, Zhang X, Peng ZG, Li JR, Jiang JD, Li YH, Song DQ.
    ChemMedChem; 2013 Sep 01; 8(9):1545-53. PubMed ID: 23881611
    [Abstract] [Full Text] [Related]

  • 12. Identification and Structure-Activity Relationships of Diarylhydrazides as Novel Potent and Selective Human Enterovirus Inhibitors.
    Han X, Sun N, Wu H, Guo D, Tien P, Dong C, Wu S, Zhou HB.
    J Med Chem; 2016 Mar 10; 59(5):2139-50. PubMed ID: 26885567
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
    Chern JH, Shia KS, Hsu TA, Tai CL, Lee CC, Lee YC, Chang CS, Tseng SN, Shih SR.
    Bioorg Med Chem Lett; 2004 May 17; 14(10):2519-25. PubMed ID: 15109643
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.
    Zhou S, Breitenbach JM, Borysko KZ, Drach JC, Kern ER, Gullen E, Cheng YC, Zemlicka J.
    J Med Chem; 2004 Jan 29; 47(3):566-75. PubMed ID: 14736238
    [Abstract] [Full Text] [Related]

  • 16. SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.
    Tang S, Li YH, Cheng XY, Li YH, Wang HQ, Kong LY, Zhang X, Jiang JD, Song DQ.
    Future Med Chem; 2016 Apr 29; 8(5):495-508. PubMed ID: 26867658
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines.
    Braendvang M, Gundersen LL.
    Bioorg Med Chem; 2007 Nov 15; 15(22):7144-65. PubMed ID: 17804243
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles.
    De Palma AM, Heggermont W, Leyssen P, Pürstinger G, Wimmer E, De Clercq E, Rao A, Monforte AM, Chimirri A, Neyts J.
    Biochem Biophys Res Commun; 2007 Feb 16; 353(3):628-32. PubMed ID: 17194441
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and evaluation of 2-amino-9-(3-hydroxymethyl-4-alkoxycarbonyloxybut-1-yl)purines as potential prodrugs of penciclovir.
    Kim DK, Lee N, Kim YW, Chang K, Kim JS, Im GJ, Choi WS, Jung I, Kim TS, Hwang YY, Min DS, Um KA, Cho YB, Kim KH.
    J Med Chem; 1998 Aug 27; 41(18):3435-41. PubMed ID: 9719596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.